Related Experiment Video
Updated: Dec 24, 2025

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
Published on: July 10, 2017
Use of Thromboelastography to Guide Platelet Infusion in a Patient with Wiskott-Aldrich Syndrome Undergoing Renal
Ammar Al Midani1, Ciara Donohue, Peter Berry
1>From the Renal Transplant Unit, Royal Free Hospital, NHS Foundation Trust, London, United Kingdom.
Abstract:
Wiskott-Aldrich syndrome is a rare primary immuno-deficiency disorder that is characterized by a triad of microthrombocytopenia, eczema, and recurrent infections. Progression to end-stage renal failure is common in survivors due to immunoglobulin A nephropathy. We describe the case of a 24-year-old male with Wiskott-Aldrich syndrome. The patient had previous hematopoietic stem cell transplant and was on hemodialysis due to end-stage renal failure. He subsequently underwent living-donor renal transplant from his mother as the donor. This is only the fifth case of renal transplant in a patient with Wiskott-Aldrich syndrome in the world. In all cases, the perioperative management of hemostatic function has been crucial. We used thromboelastography to guide our hemostatic decisions rather than platelet count, thus reducing exposure to unnecessary platelet transfusions and without increased bleeding risk. Our patient had an uneventful course after living-donor kidney transplant.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Continuous Renal Replacement Therapy
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Kidney Transplant II: Surgical Procedure

